Navigation Links
Trending HealthEconomics.Com Pharma Pricing, Reimbursement, and Health Policy Stories Feature Rising Trend in Pharma Price Cuts to Secure Reimbursement
Date:12/14/2012

Ponte Vedra Beach, FL (PRWEB) December 13, 2012

The most-read story on HealthEconomics.Com HealthCare Value and Market Access News this week examines the growing trend of pharmaceutical companies to drop prices by up to one-half to convince the National Institute for Health and Clinical Excellence (NICE) that the drugs are cost-effective. According to NICE Chairman Michael Rawlins, these “commercially confidential” price cuts are becoming both more common and larger, approaching 50% discounts. This poses implications for international reference pricing which examines drug prices in other countries in order to set a reimbursable price with the intent to contain growth in pharmaceutical expenditures. This story and another describing the discount offered by Bristol-Myers Squibb Co. on their drug for rheumatoid arthritis reversing a rejection in 2011 are covered more in-depth on HealthEconomics.Com.

Another top story on HealthEconomics.Com explored the response by major employers in the United States to deny health insurance to newly hired employees who work fewer than 30 hours per week, starting in January 2013. Many health care policy experts believe this shift by the nation’s largest employer to be an attempt to shift costs of paying for its employees’ health insurance to place the burden on the federal government, with the implementation of the Affordable Care Act. This story is featured on HealthEconomics.Com News on Health Policy.

In a story on unintended consequences associated with health reform, Quebec
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. WuXi PharmaTech Announces Third-Quarter 2011 Results
3. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
4. Pharmasset Reports Fiscal Year End 2011 Financial Results
5. Internal and External Communications Excellence for the Pharmaceutical Industry: Increasing Organizational Effectiveness
6. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
7. PRA Expert to Present at Pharmacovigilance Conference
8. Nutra Pharma Announces Publication of a New Mechanism Study of Alpha-Cobratoxin in the Treatment of Pain
9. InnoPharma Completes $15 Million Series A Financing
10. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
11. ViroPharma to Participate in Two December Healthcare Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014  Now available is ... home. Rehealth Regenerative Therapies , located in ... other physically active people a new health option: ... Regardless of age, countless patients suffer from joint and ... such as muscle tears, torn rotator cuff, tennis elbow, ...
(Date:7/24/2014)... Calif. , July 24, 2014  Asterias ... in the emerging field of regenerative medicine, announced ... of a presentation to investors on Tuesday, July ... PDT.  The presentation will include an overview of ... access the webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics at ...
(Date:7/24/2014)... , July 24, 2014  ECC West Africa, ... Colorado with University College Hospital (UCH) Ibadan ... development project to finance, design, construct, and operate and ... Nigeria . Under the first of the ... scoping documents and funding applications. UCH Ibadan intends to ...
(Date:7/24/2014)... on sophisticated equipment, trained personnel, and detection dogs ... terrorist attacks. A revolutionary new electronic chip with ... job much easier. , The groundbreaking nanotechnology-inspired sensor, ... University ,s School of Chemistry and Center for ... company Tracense, picks up the scent of explosives ...
Breaking Biology Technology:Stem Cells In Sports Injuries, Joints And Muscular Pain 2Stem Cells In Sports Injuries, Joints And Muscular Pain 3Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria 2Nano-sized chip 'sniffs out' explosives far better than trained dogs 2
... device and technology industries are a major strength of ... the economic health of the state. These industries ... to healthcare technologies and devices. Concentration of this ... producing products and services in the device and technology ...
... I recently traveled to an event in Madison, Wis. that ... Network. It was designed to bring together three geographic locations ... , ,Now ePrairies third eXtreme Networking event (but ... derived from a methodology for dating where men and women ...
... Summit started today. It will be interesting to see if ... Summits. My hunch is that it will not and we ... nothing about high technology. As in the past, the hall will ... are clueless about what to do. , ,If Governor ...
Cached Biology Technology:Mike Rosen Reviews - eXtreme Networking in Madison 2Mike Rosen Reviews - eXtreme Networking in Madison 3Create a Governors Technology Summit 2
(Date:7/24/2014)... Scientists at The New York Stem Cell Foundation ... creating a viable cell replacement therapy for multiple ... For the first time, NYSCF scientists generated induced ... of patients with primary progressive multiple sclerosis and ... these stem cells into becoming oligodendrocytes, the myelin-forming ...
(Date:7/24/2014)... how wildlife loss leads to conflict among people around ... Conservation Society (WCS) Health & Ecosystems: Analysis of Linkages ... interdisciplinary approach to tackle global biodiversity decline. , The ... the world,s people and provides protein for more than ... as no surprise that today,s unprecedented loss of wildlife, ...
(Date:7/24/2014)... NY - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. ... the long-term, randomized, active control Phase 3 study of ... phosphate binder, for the treatment of hyperphosphatemia in patients ... study (PhosphatE binding and iRon delivery with FErric CiTrate ... Journal of the American Society of Nephrology ( ...
Breaking Biology News(10 mins):NYSCF scientists one step closer to cell therapy for multiple sclerosis patients 2New study draws links between wildlife loss and social conflicts 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4
... lost from West Antarctica and the Antarctic peninsula over the ... Bristol and published online this week in Nature Geoscience. ... roughly stable, with neither loss nor accumulation over the past ... and colleagues estimated the flux of ice from the ice ...
... a survey across the entire human genome, an international ... Health (NIH) has found evidence that common genetic variants ... role in human height. The findings were released today ... Genetics. The variants most strongly associated with height ...
... Bering Sea. But during this century, the seas ... adapt to greenhouse conditions. All the fish that ends ... USC marine ecologist Dave Hutchins, whose former student at the ... in Marine Ecology Progress Series, a leading journal in the ...
Cached Biology News:Antarctic ice loss 2Researchers uncover new piece to the puzzle of human height 2Researchers uncover new piece to the puzzle of human height 3Researchers uncover new piece to the puzzle of human height 4Greenhouse ocean may downsize fish 2Greenhouse ocean may downsize fish 3
... presents PsiPort Mass Directed Auto Purification ... data acquisition system designed for automated ... life science and pharmaceutical discovery programs. ... to simplify high throughput mass directed ...
SP6 RNA Polymerase, 50 l, 20 U/l ,Cap Scribe Buffer, 100 l, 5x conc....
... catalyzes the transfer of the ... 5-terminus of polynucleotides or to ... The enzyme, purified from recombinant ... to phosphorylate RNA, DNA and ...
... Ascent is the first nephelometer ... microplates. Nepheloskan measures light scattering ... for particle quantification. This makes ... in drug discovery, immunoprecipitation, and ...
Biology Products: